Respiratory infection test kit RIDA®GENE

respiratory syncytial virusclinicallaboratory

For in vitro diagnostic use. The RIDA®GENE RSV & hMPV test, performed on Roche LightCycler® 480 II, is a multiplex real-time RT-PCR for the direct qualitative detection and differentiation of respiratory syncytial virus (A/B) and human metapneumovirus (A/B) RNA in untreated human nasal/throat swabs and BAL from persons with signs and symptoms of acute respiratory infection. The RIDA®GENE RSV & hMPV test is intended to support the diagnosis of viral (RSV & hMPV) infections in patients with symptoms of respiratory infection in connection with other clinical and laboratory findings. Negative results do not rule out infection with RSV or hMPV and should not be used as the sole basis for diagnosis. The product is intended for professional use. General information: The human respiratory syncytial virus (RSV) is considered one of the most potent pathogens for acute infections of the lower respiratory tract such as lung inflammation and bronchiolitis. A high incidence of RSV infections has been found especially in children less than 6 months old. RSV is associated with elevated morbidity and mortality in not just children but also the elderly, patients with prior illnesses, and immunocompromised adults. RSV is a nonsegmented, enveloped RNA virus that belongs to the Pneumoviridae family. The viral genome, a single-stranded RNA (ssRNA) molecule, codes for 11 proteins. Given the antigenicity of its G protein, the strain is divided into two antigen groups: RSV A and B.